PMC:7558914 / 23845-24019
Annnotations
LitCovid_Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T25 | 39-46 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T26 | 39-46 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 592 | 81-89 | Species | denotes | patients | Tax:9606 |
| 599 | 39-46 | Chemical | denotes | heparin | MESH:D006493 |
| 613 | 72-80 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T152 | 0-174 | Sentence | denotes | For this reason, the administration of heparin has been recommended for COVID-19 patients according to expert consensus [4,31], although its efficacy remains to be validated. |